New York, May 30, 2026, 14:08 EDT
CareCloud (CCLD) finished at $2.35, rising 1.29% Friday and up roughly 3.1% for the week. The U.S. trading week was shortened by the Memorial Day holiday. Nasdaq was closed Saturday and will reopen Monday.
Small healthcare-tech player CareCloud bounced at the end of the week after its bolt-on acquisition news, lifting the stock even as the move wasn’t big in size but hit at a key moment. Wall Street’s major indexes also advanced for the week, with the S&P 500 notching another gain in what traders called a broad risk-on tape.
CareCloud said Tuesday it bought Empower Healthcare & Compliance Partners, an advisory firm focused on healthcare compliance. The deal closed May 22. CareCloud said the acquisition brings new services like revenue integrity, M&A support, privacy, security, and compliance and ethics consulting. CEO Stephen Snyder said “compliance is now a top priority for healthcare providers.” Empower founder Mitchell Brie said the deal brings “scale we could only have imagined.” GlobeNewswire
CareCloud said it used cash flow from its operations to fund the deal, with no expectation the acquisition will make a significant difference to 2026 earnings. Services roll out to clients in the second quarter, and the company is targeting release of its AI-powered compliance software in the second half. No quick bump to earnings was promised.
CareCloud is betting on cross-selling. The company offers revenue cycle management, or RCM, helping medical providers with billing and collections. It also sells practice-management and electronic health record tools, reaching over 45,000 providers. Now it’s adding compliance work as another product to pitch to those same customers.
CareCloud’s first-quarter report is still driving the stock. Revenue came in at $31.3 million, up 13% year over year. Net income was $922,000, but after preferred dividends, common shareholders posted a 1 cent per share loss. The company kept its 2026 outlook, calling for $128 million to $132 million in revenue and $29 million to $31 million in adjusted EBITDA. That measure takes out interest, taxes, depreciation, amortization and some other costs.
Stocks got a lift from a stronger market. “The rally has really been driven by earnings,” Ohsung Kwon, equity and quantitative strategist at Wells Fargo Investment Institute, told Reuters as U.S. shares climbed into the month’s close. That matters for a small cap with light volume and an AI angle.
But the picture is mixed. CareCloud is small when stacked against healthcare IT and RCM players like athenahealth, eClinicalWorks and R1 RCM. The company itself flags the risk that bigger competitors could outpace it on pricing, new products and AI. Risks also include provider consolidation, integrating acquisitions and exposure to offshore operations.
Jobs data will dominate early this week. U.S. markets are waiting for the June 5 payrolls figures, with Reuters surveys pointing to 85,000 new jobs in May and a 4.3% jobless rate. If the report runs hotter or suggests inflation, “it could change the outlook for Fed policy,” Charles Schwab strategist Liz Ann Sonders told Reuters. Reuters
CareCloud faces a clear test this Monday. Either investors keep backing the Empower deal as a solid add-on, or momentum drops off as the market waits for management to show revenue from the compliance rollout. With little fresh news around, shares could track small-cap health-tech names and trade with demand for AI-driven software.
